Insulin Infusion Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Market is Segmented by Component (Pump Device, Infusion Set, and Reservoir) and by Geography.

Market Snapshot

insulin infusion pumps market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: North America
Largest Market: North America
CAGR: 0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

  • The insulin infusion pump market is set to witness a CAGR of 7.51%, during the forecast period. Insulin infusion pump works as an alternative to the traditional system of daily injections or an insulin pen.
  • Insulin infusion pumps reduce the large swings in blood glucose level, lessen pain, and deliver more accurately than injections. The scheduling of meal timings is not required when using pumps.
  • This makes infusion pumps more user-friendly for patients. Insulin therapy is also known as continuous subcutaneous insulin infusion (CSII). It is an efficient and flexible method of insulin delivery.
  • The insulin pump has evolved and is more reliable than it was previously. CSII technology has witnessed numerous technological advancements, like the integration of continuous glucose monitoring with the pump. Now, insulin pumps can control the algorithm that automatically delivers the insulin, after analyzing the blood glucose reading

Scope of the Report

The insulin infusion pumps market is segmented into the device, infusion set, and reservoir. The report is also segmented into five regions: North America, Asia - Pacific, Europe, Middle East & Africa, and Latin America.

By Product (Value and Volume, 2012-2024)
Insulin Pumps
Infusion Sets
Reservoirs
Geography
North America
United States (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Canada (Value and Volume, 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of North America (Value and Volume, 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Asia - Pacific
Japan (Value and Volume, 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
South Korea (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
China (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
India (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Australia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Vietnam (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Malaysia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Indonesia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Philippines (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Thailand (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Asia - Pacific (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Europe
United Kingdom (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
France (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Germany (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Italy (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Spain (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Russia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Europe (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Latin America
Mexico (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Brazil (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Latin America (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Middle East & Africa
Saudi Arabia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Iran (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Egypt (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Oman (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
South Africa (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Middle East & Africa (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Insulin Pumps Market is Registering a CAGR of 7% in the Forecast Period

  • Owing to the rising rate of obesity, growing genetic factors for type-2 diabetes, and the increasing number of type-1 diabetes patients, it is likely that the insulin infusion pumps market will continue to grow. 
  • Insulin pumps use is high among the type-1 diabetes population. It is also growing in type-2 patients. The ratio of children to adult, or type-1 to type-2, patient’s usage of insulin pumps varies across countries.
insulin infusion pumps market

North America Holds the Highest Market Share

  • North America holds the highest market share in the insulin pumps market and is also expected to register the highest CAGR of 9.05% in the forecast period, because of the favorable reimbursement policy. Although the pump and its supplies (tubing, insulin cartridges, and infusion sets) continue to be expensive, insurance coverage has improved considerably over the years.
insulin infusion pumps market

Competitive Landscape

  • Animas had to exit the insulin pumps market, as the company has admitted that rising competition was the reason for them to leave the market.
  • Medtronic is the market leader and is expected to maintain its position during the forecast period.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product (Value and Volume, 2012-2024)

      1. 5.1.1 Insulin Pumps

      2. 5.1.2 Infusion Sets

      3. 5.1.3 Reservoirs

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States (Value and Volume 2012-2024)

          1. 5.2.1.1.1 By Insulin Pump Devices

          2. 5.2.1.1.2 By Infusion Sets

          3. 5.2.1.1.3 By Reservoirs

        2. 5.2.1.2 Canada (Value and Volume, 2012-2024)

          1. 5.2.1.2.1 By Insulin Pump Devices

          2. 5.2.1.2.2 By Infusion Sets

          3. 5.2.1.2.3 By Reservoirs

        3. 5.2.1.3 Rest of North America (Value and Volume, 2012-2024)

          1. 5.2.1.3.1 By Insulin Pump Devices

          2. 5.2.1.3.2 By Infusion Sets

          3. 5.2.1.3.3 By Reservoirs

      2. 5.2.2 Asia - Pacific

        1. 5.2.2.1 Japan (Value and Volume, 2012-2024)

          1. 5.2.2.1.1 By Insulin Pump Devices

          2. 5.2.2.1.2 By Infusion Sets

          3. 5.2.2.1.3 By Reservoirs

        2. 5.2.2.2 South Korea (Value and Volume 2012-2024)

          1. 5.2.2.2.1 By Insulin Pump Devices

          2. 5.2.2.2.2 By Infusion Sets

          3. 5.2.2.2.3 By Reservoirs

        3. 5.2.2.3 China (Value and Volume, 2012 - 2024)

          1. 5.2.2.3.1 By Insulin Pump Devices

          2. 5.2.2.3.2 By Infusion Sets

          3. 5.2.2.3.3 By Reservoirs

        4. 5.2.2.4 India (Value and Volume, 2012 - 2024)

          1. 5.2.2.4.1 By Insulin Pump Devices

          2. 5.2.2.4.2 By Infusion Sets

          3. 5.2.2.4.3 By Reservoirs

        5. 5.2.2.5 Australia (Value and Volume, 2012 - 2024)

          1. 5.2.2.5.1 By Insulin Pump Devices

          2. 5.2.2.5.2 By Infusion Sets

          3. 5.2.2.5.3 By Reservoirs

        6. 5.2.2.6 Vietnam (Value and Volume, 2012 - 2024)

          1. 5.2.2.6.1 By Insulin Pump Devices

          2. 5.2.2.6.2 By Infusion Sets

          3. 5.2.2.6.3 By Reservoirs

        7. 5.2.2.7 Malaysia (Value and Volume, 2012 - 2024)

          1. 5.2.2.7.1 By Insulin Pump Devices

          2. 5.2.2.7.2 By Infusion Sets

          3. 5.2.2.7.3 By Reservoirs

        8. 5.2.2.8 Indonesia (Value and Volume, 2012 - 2024)

          1. 5.2.2.8.1 By Insulin Pump Devices

          2. 5.2.2.8.2 By Infusion Sets

          3. 5.2.2.8.3 By Reservoirs

        9. 5.2.2.9 Philippines (Value and Volume, 2012 - 2024)

          1. 5.2.2.9.1 By Insulin Pump Devices

          2. 5.2.2.9.2 By Infusion Sets

          3. 5.2.2.9.3 By Reservoirs

        10. 5.2.2.10 Thailand (Value and Volume, 2012 - 2024)

          1. 5.2.2.10.1 By Insulin Pump Devices

          2. 5.2.2.10.2 By Infusion Sets

          3. 5.2.2.10.3 By Reservoirs

        11. 5.2.2.11 Rest of Asia - Pacific (Value and Volume, 2012 - 2024)

          1. 5.2.2.11.1 By Insulin Pump Devices

          2. 5.2.2.11.2 By Infusion Sets

          3. 5.2.2.11.3 By Reservoirs

      3. 5.2.3 Europe

        1. 5.2.3.1 United Kingdom (Value and Volume, 2012 - 2024)

          1. 5.2.3.1.1 By Insulin Pump Devices

          2. 5.2.3.1.2 By Infusion Sets

          3. 5.2.3.1.3 By Reservoirs

        2. 5.2.3.2 France (Value and Volume, 2012 - 2024)

          1. 5.2.3.2.1 By Insulin Pump Devices

          2. 5.2.3.2.2 By Infusion Sets

          3. 5.2.3.2.3 By Reservoirs

        3. 5.2.3.3 Germany (Value and Volume, 2012 - 2024)

          1. 5.2.3.3.1 By Insulin Pump Devices

          2. 5.2.3.3.2 By Infusion Sets

          3. 5.2.3.3.3 By Reservoirs

        4. 5.2.3.4 Italy (Value and Volume, 2012 - 2024)

          1. 5.2.3.4.1 By Insulin Pump Devices

          2. 5.2.3.4.2 By Infusion Sets

          3. 5.2.3.4.3 By Reservoirs

        5. 5.2.3.5 Spain (Value and Volume, 2012 - 2024)

          1. 5.2.3.5.1 By Insulin Pump Devices

          2. 5.2.3.5.2 By Infusion Sets

          3. 5.2.3.5.3 By Reservoirs

        6. 5.2.3.6 Russia (Value and Volume, 2012 - 2024)

          1. 5.2.3.6.1 By Insulin Pump Devices

          2. 5.2.3.6.2 By Infusion Sets

          3. 5.2.3.6.3 By Reservoirs

        7. 5.2.3.7 Rest of Europe (Value and Volume, 2012 - 2024)

          1. 5.2.3.7.1 By Insulin Pump Devices

          2. 5.2.3.7.2 By Infusion Sets

          3. 5.2.3.7.3 By Reservoirs

      4. 5.2.4 Latin America

        1. 5.2.4.1 Mexico (Value and Volume, 2012 - 2024)

          1. 5.2.4.1.1 By Insulin Pump Devices

          2. 5.2.4.1.2 By Infusion Sets

          3. 5.2.4.1.3 By Reservoirs

        2. 5.2.4.2 Brazil (Value and Volume, 2012 - 2024)

          1. 5.2.4.2.1 By Insulin Pump Devices

          2. 5.2.4.2.2 By Infusion Sets

          3. 5.2.4.2.3 By Reservoirs

        3. 5.2.4.3 Rest of Latin America (Value and Volume, 2012 - 2024)

          1. 5.2.4.3.1 By Insulin Pump Devices

          2. 5.2.4.3.2 By Infusion Sets

          3. 5.2.4.3.3 By Reservoirs

      5. 5.2.5 Middle East & Africa

        1. 5.2.5.1 Saudi Arabia (Value and Volume, 2012 - 2024)

          1. 5.2.5.1.1 By Insulin Pump Devices

          2. 5.2.5.1.2 By Infusion Sets

          3. 5.2.5.1.3 By Reservoirs

        2. 5.2.5.2 Iran (Value and Volume, 2012 - 2024)

          1. 5.2.5.2.1 By Insulin Pump Devices

          2. 5.2.5.2.2 By Infusion Sets

          3. 5.2.5.2.3 By Reservoirs

        3. 5.2.5.3 Egypt (Value and Volume, 2012 - 2024)

          1. 5.2.5.3.1 By Insulin Pump Devices

          2. 5.2.5.3.2 By Infusion Sets

          3. 5.2.5.3.3 By Reservoirs

        4. 5.2.5.4 Oman (Value and Volume, 2012 - 2024)

          1. 5.2.5.4.1 By Insulin Pump Devices

          2. 5.2.5.4.2 By Infusion Sets

          3. 5.2.5.4.3 By Reservoirs

        5. 5.2.5.5 South Africa (Value and Volume, 2012 - 2024)

          1. 5.2.5.5.1 By Insulin Pump Devices

          2. 5.2.5.5.2 By Infusion Sets

          3. 5.2.5.5.3 By Reservoirs

        6. 5.2.5.6 Rest of Middle East & Africa (Value and Volume, 2012 - 2024)

          1. 5.2.5.6.1 By Insulin Pump Devices

          2. 5.2.5.6.2 By Infusion Sets

          3. 5.2.5.6.3 By Reservoirs

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2012-2024)

    2. 6.2 Type-2 Diabetes Population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Medtronic

      2. 7.1.2 Insulet

      3. 7.1.3 Roche

      4. 7.1.4 Animas

      5. 7.1.5 Tandem

      6. 7.1.6 Ypsomed

      7. 7.1.7 Cellnovo

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Roche

      2. 7.2.2 Animas

      3. 7.2.3 Medtronic

      4. 7.2.4 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Insulin Infusion Pumps Market market is studied from 2018 - 2026.

The Insulin Infusion Pumps Market is growing at a CAGR of 0% over the next 5 years.

North America is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Medtronic, Roche, Animas, Ypsomed, Insulet are the major companies operating in Insulin Infusion Pumps Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!